After a grim year of sliding share values in 2011--the biotech sector was down a median 25%--early 2012 has seen a big improvement in stock performance, according to some figures reviewed in a buy-side panel discussion at the BIO CEO & Investor Conference in New York Monday. And in a new BIO survey, ...www.fiercebiotech.comPeanut Gallery:
05/19/2012 08:55:13 -
The best of times, the worst of times? - After a grim year of sliding share values in 2011--the biotech sector was down a median 25%--early 2012 has seen a big improvement in stock performance, according to some figures reviewed in a buy-side panel discussion at the BIO CEO & Investor Conference in New York Monday. And in a new BIO survey, ...www.fiercebiotech.comPeanut Gallery:
Gilead to Buy Pharmasset for $11 BillionNYTimes.com : Nov 21, 2011 ... Under the terms of the deal, Gilead Sciences will pay $137 a share in cash for Pharmasset, 89 percent above its closing share price on Friday.dealbook.nytimes.com/.../gilead-to-buy-pharmasset-for -11-billion/- Cached :
Gilead bets $11 billion on hepatitis in Pharmasset deal | Reuters : Nov 21, 2011 ... (Reuters) - Gilead Sciences Inc struck a deal to buy biotechnology company Pharmasset Inc for about $11 billion in a huge and risky bet on the ...www.reuters.com/.../us-gilead-pharmasset-idUSTRE7AK0XU201 11121- Cached :
Gilead's $11 Billion GambitWSJ.com : Nov 22, 2011 ... Pharmasset, a Princeton, N.J., company with just over 80 employees and no commercial products, is developing a compound that Gilead and ...online.wsj.com/.../SB100014240529702044434045770518006400 24264.html- Cached
: Gilead Sciences 1Q profit down on Pharmasset costsCBS News : Apr 26, 2012 ... Gilead Sciences 1Q profit down on Pharmasset costs. FOSTER CITY, Calif. HIV drug maker Gilead Sciences Inc.'s profit dropped 32 percent ...www.cbsnews.com/.../gilead-sciences-1q-profit-down-on-pha rmasset-costs/- Cached
- Pharmasset, Inc.Investor Relations : You will find key shareholder information and financial reports available to help put Pharmasset, Inc.'s financial performance into perspective.investor.pharmasset.com/- Cached :
Pharmasset - Gilead Sciences, Inc. : On January 17, 2012, Pharmasset became a wholly-owned subsidiary of Gilead Sciences, Inc. You are now being re-directed to the Gilead website. If you are ...www.gilead.com/pharmasset.html- Cached
: Pharmasset - Wikipedia, the free encyclopedia : Pharmasset Inc. (NASDAQ: VRUS) is a pharmaceutical company based in Princeton, New Jersey in the United States. The company develops antiviral drugs for ...en.wikipedia.org/wiki/Pharmasset- Cached
: Pharmasset striding into Ph3 to lead pack of oral Hep C drug ... : Nov 1, 2011 ... Pharmasset ($VRUS) has grabbed a leading post in the race for new oral therapies against the hepatitis C virus, initiating a Phase III program ...www.fiercebiotech.com/story/pharmasset...ph3.../2011-11-0 1- Cache
d :
The Need To Reinvent Business - May 2012 Forbes.com: I want to share with an article that I wrote with my friend Leberecht, of frog, a version of which appeared on Forum Blog, official blog of World Economi...
G8 Will Be Told: Five Reasons Euro Crisis Needs More Austerity - May 2012 Forbes.com: New York Times yesterday called on Chancellor Merkel of Germany to take a softer line on Europe's austerity program by time reaches G8 at Camp David. Paul Krugma...
Do Brands Need Celebrities? - May 2012 Forbes.com: Forbes list of World?s Most Powerful Celebrities is fascinating to me. Dorothy Pomerantz her team a remarkable of putting list together. However...
What is YSB? It's a spyware free, easy to use toolbar for IE that lets you search all the big 3 search engines from one place!
Concerned about spyware? None here! It is non-invasive and easier to uninstall than to install. We HATE spyware and viruses, but we definitely recommend this toolbar.
